NAFDAC Newsroom
The list below provides information gathered from press releases and other public notices of The Agency
Highlights
-
Public Alert No. 11/2025 – Recall of Various Products by Sun Pharma, Glenmark, and Zydus Pharmaceuticals Over Manufacturing Issues
-
Executive Summary of the International Council for Harmonization (ICH) Q7 (Good Manufacturing Practice Guideline for Active Pharmaceutical Ingredients) Training for Regulators and Industry
-
Executive Summary for International Council for Harmonization (ICH) Q1 Stability Guideline Workshop
-
Public Alert No. 010/2025 – Alert on the Sale of a Fake Product Named Wonder Calcium by Health and Hygiene
-
Public Alert No. 09/2025 – Voluntary Recall of Zovirax IV Infusion by GlaxoSmithKline (GSK) Limited Due to Potential Quality Defects
-
Press Briefing on the Regulatory Framework for Bioequivalence and it’s Relevance to the Nigerian Market
News
- Press Announcements
- Speeches
- Events
- Approvals
- Warning Letters
- Notes to Industries
- Recalls & Alerts
- Testimony
Profile & Photos
Quick Links
- Approval of NAFDAC Regulated Products
- Freedom of Information
Events
- NAFDAC Meetings Conferences & Workshops
- Campus Tours
- Sensitization
- Content Current as of January 22, 2024
More Actions
Was this helpful?
Thanks for your feedback!
